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Abstract
The available tools for conditional gene expression in Plasmodium falciparum are limited. Here, 
to enable reliable control of target gene expression, we build a system to efficiently modulate 
translation. We overcame several problems associated with other approaches for regulating gene 
expression in P. falciparum. Specifically, our system functions predictably across several native 
and engineered promoter contexts, and affords control over reporter and native parasite proteins 
irrespective of their subcellular compartmentalization. Induction and repression of gene expression 
are rapid, homogeneous, and stable over prolonged periods. To demonstrate practical application 
of our system, we used it to reveal direct links between antimalarial drugs and their native parasite 
molecular target. This is an important out come given the rapid spread of resistance, and 
intensified efforts to efficiently discover and optimize new antimalarial drugs. Overall, the studies 
presented highlight the utility of our system for broadly controlling gene expression and 
performing functional genetics in P. falciparum.
Introduction
Malaria is a disease caused by several species of Plasmodium parasites, and continues to 
bean enormous burden on global human health. Few preventative and treatment options are 
available. A key barrier to defining parasite vulnerabilities that can be targeted for 
therapeutic purposes has been the lack of a more complete genetic toolkit. For P. 
falciparum, the parasite responsible for the majority of human malaria deaths, the RNA 
interference strategy that has proven invaluable in other organisms is unavailable1. 
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Conditional recombination to delete genes has been recently demonstrated2, but a generally 
applicable system for reversible regulation of gene expression remains highly sought. 
Methods to achieve robust transcriptional regulation remain elusive, though some attempts 
have been described3, 4. A high degree of expression heterogeneity, and the unpredictable 
and rapid loss of regulatory behavior have significantly limited their use in functional 
studies.3, 5 For these reasons, efforts to functionally regulate parasite genes, such as PfCRT, 
using this approach were unsuccessful5. Recently, a modified version of this inducible 
transcription system has been described, and functional control of gene expression was 
achieved in the genetically tractable rodent model parasite, P. berghei4. However, functional 
regulation of gene expression in the more recalcitrant P. falciparum was not reported. 
Additionally, while control of GFP reporter expression was assessed in P. falciparum, flow 
cytometry data on the cell-to-cell variability of this regulation is unavailable. Thus, it is 
unclear whether the key issues of heterogeneous expression and spontaneous loss of 
regulation observed specifically in P. falciparum have been resolved. From this perspective, 
the long-term reliability of existing inducible transcription systems in P. falciparum is 
unknown. An alternative system based on the inducible degradation of targeted proteins has 
been used effectively in some instances6, 7. However, it is not generalizable to many genes, 
as the target protein must:(1) tolerate fusion to a ligand-sensitive degradation domain (DD); 
and (2) be accessible to the parasite’s proteasome. This limits reliably performing functional 
studies on a substantial number of proteins that are trafficked to various subcellular 
compartments8–10 and the host red blood cell11. Recently, the glmS ribozyme has been used 
to post-transcriptionally control gene expression in P. falciparum12. However, together with 
the DD system and its limitations described above, these comprise an extremely limited 
toolkit for achieving reversible control of gene expression in P. falciparum when compared 
to the many robust and orthogonal options available for regulating gene expression in other 
organisms.
We previously engineered a system for inducible control of eukaryotic translation that uses a 
protein-RNA interaction controlled by a tetracycline analog13 (Fig. 1a). As the cytosolic 
translation machinery in P. falciparum is highly conserved with other eukaryotes14, we 
reasoned that we should be able to implement our system to control translation in the 
parasite. Three key attributes of this system are that it enables experimental control of gene 
expression independently of: (1) transcriptional control; (2) modification of the target 
protein in a manner that potentially compromises its function; and (3) the specific 
compartment to which target proteins are trafficked. These satisfy important criteria for 
defining a broadly applicable gene regulatory system. Here, we demonstrate implementation 
of our TetR-aptamer system to control both reporter and native gene expression in P. 
falciparum in a manner that meets the criteria outlined above. We also show that this system 
is useful for studying the function of native parasite genes.
Results
Regulatory system design and functional validation
We used a plasmid-based transient screening approach to establish the basic functionality of 
our system in P. falciparum. We constructed a3D7 parasite strain stably expressing TetR 
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from a single-copy chromosomal locus (Supplementary Fig. 1a,b and Supplementary Table 
1), and transfected it with dual-luciferase reporter plasmids expressing firefly luciferase 
(FLuc) under the control of the TetR-binding aptamer 5-1.17,and a reference Renilla 
luciferase (RLuc) (Fig. 1b). Addition of an hydro tetracycline (aTc) to transiently transfected 
parasites yielded an ~80% change in FLuc expression (Fig. 1c), similar to what we observed 
in yeast13. This regulatory behavior was consistent across different promoter/5′-untranslated 
region (5′UTR) contexts, with a similar dynamic range observed when regulating the hsp86 
and calmodulin5′UTRs. The mutant sequence 5-1.17m2, which does not interact with 
TetR13, yielded no aTc-dependent regulation, as expected.
To further characterize this system, we built single-plasmids expressing aptamer-regulated 
FLuc, a constitutive reference RLuc, TetR, and a G418-selectable marker (Fig. 1b). These 
constructs express polycistronic messages that use 2A-like peptides to yield multiple distinct 
proteins15. A key benefit of this ‘all-in-one’ design is that it obviates the need for a 
dedicated TetR-expressing background line, and makes this system broadly useful in any P. 
falciparum strain of interest. We transfected single-plasmid constructs into parasite strain 
Dd2 and measured aTc-dependent luciferase expression after G418 selection. In this context, 
the system produced a similar ~80% regulation upon aTc addition (Fig. 1d). FLuc 
expression increased in a sigmoidal manner with aTc, reaching a maximum at an aTc 
concentration well below the minimum that inhibits parasite growth (Supplementary Fig.2 
a,b). To establish that regulation occurs at the translational level, and not via a change in 
steady-state mRNA concentration, we measured FLuc mRNA by quantitative PCR 
(Supplementary Fig. 3a). We also verified by Western blot analysis that aTc has no impact 
on TetR expression(Supplementary Fig. 3b). Comparing aptamer-regulated and non-aptamer 
FLuc expression, we observed that inclusion of the aptamer sequence (in the absence of 
TetR binding) decreased maximal expression possible from a given 5′ UTR by about two 
fold (Fig. 1e).
Regulation dynamics during blood stage parasite development
P. falciparum develops over a 48-hour intra-erythrocytic developmental cycle (IDC) during 
which individual genes are expressed in a temporally variable manner16, 17. To best study 
the IDC, the TetR-aptamer system should allow rapid changes in target gene expression, 
with induction and washout times that are significantly less than a single IDC. We 
characterized aTc-dependent response kinetics in synchronized parasites expressing a stable 
5-1.17–FLuc or 5-1.17m2–FLuc reporter (Fig. 2). In one scenario, initially induced or 
repressed late schizont stage cultures (40 hours post invasion) were washed, and each 
maintained thereafter in either the presence or absence of aTc over the next IDC (Fig. 2a). 
At 12 h post aTc addition, FLuc expression was indistinguishable from a culture 
continuously exposed to aTc. Repression after aTc washout was similarly rapid, and FLuc 
levels returned to basal repressed levels early into the IDC. In a second scenario, induction 
or washout was performed soon after invasion (early ring stage) and FLuc expression was 
monitored with in the same IDC (Fig. 2b). The changes in expression were nearly complete 
at the first time point (5 h), although the apparent magnitude of FLuc repression after aTc 
washout was not as complete under these conditions. The inherent turnover rate of pre-
synthesized FLuc protein, rather than TetR-aptamer interaction dynamics, is likely rate 
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limiting and gives rise to the residual FLuc activity detected in the aTc washout phase of 
these experiments. Consistent with this interpretation, engineered mRNA and protein 
destabilizing signals are needed to improve the reliability of FLuc as a reporter of decreased 
protein synthesis in rapid kinetics studies18.
Regulation in chromosomal context and of subcellular targets
Towards adapting the TetR-aptamer system to regulate endogenous gene expression, we 
tested its regulatory performance using integrated reporter genes. We first integrated our 
single-plasmid attP+ constructs (Supplementary Fig. 4a,b) at single copy into the 
chromosome at the cg6 locus of NF54-attB parasites19 using the Bxb1 site-specific 
recombinase20. The expression of both luciferase and green fluorescent protein (GFP) 
reporters were regulated similarly (~80%) in this context (Supplementary Fig. 5a). 
Additionally, the GFP reporter illustrated that both the repressed and induced parasite 
populations were homogeneously regulated (Supplementary Fig. 5b). Furthermore, aTc-
dependent regulation is fully preserved with our system even after prolonged continuous 
culture (> 8 months) in both episomal and integrated contexts. Significantly, this contrasts 
with a previously reported TetR-based transcriptional system where regulation was very 
heterogeneous and unpredictably short-lived3, 5.
We then examined the utility of our system to regulate the expression of genes targeted to 
various parasite subcellular organelles and the host red blood cell while preserving proper 
trafficking. To our GFP construct, we added N-terminal targeting peptides that mediate 
trafficking to the apicoplast21, mitochondrion22, or host erythrocyte cytoplasm23, 24 
downstream of the regulatory aptamer. As translation likely initiates within the aptamer13, it 
is important to establish that the aptamer-encoded short leader peptide does not interfere 
with target protein trafficking. Direct or indirect fluorescence microscopy of live or 
antibody-probed fixed cells, respectively, revealed that including the aptamer upstream of 
the subcellular targeting sequence did not interfere with proper protein trafficking (Fig. 3a). 
Flow cytometry analysis again confirmed that aTc-dependent induction of GFP expression is 
homogeneous in these strains (Supplementary Fig. 5c). The organelle-targeted GFP 
constructs yielded lower fluorescence signal. As the signal-to-noise ratio was too low to 
accurately quantify aTc-dependent changes in GFP expression by flow cytometry, we 
quantified GFP expression by ELISA (Supplementary Fig. 5d). This analysis revealed aTc-
dependent regulation of GFP targeted to the apicoplast and mitochondrion is similar to that 
achieved during cytosolic expression. We further confirmed these findings using the native 
parasite exported protein knob-associated histidine rich protein (KAHRP; PF3D7_0202000). 
This protein is exported to the host red blood cell and associates with the cytoskeletal 
network just beneath the red blood cell membrane, which results in a rim fluorescence 
pattern upon microscopy25, 26. We constructed a P. falciparum centromere plasmid27 from 
which GFP fused to KAHRP (KAHRP-GFP)25 is expressed under the control of the native 
KAHRP upstream region (~2 kb) and regulated by aptamer 5-1.17. This plasmid uses the 
versatile ‘all-in-one’ design introduced earlier and also encodes the regulatory TetR, a 
constitutive luciferase and a selectable marker (Supplementary Fig. 6a). Parasites were 
transfected with this KAHRP-GFP construct and induced with aTc displayed prominent 
GFP signal closely associated with the red blood cell plasma membrane, indicating the 
Goldfless et al. Page 4
Nat Commun. Author manuscript; available in PMC 2015 May 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
expected export and localization of this protein (Fig. 3b). Flow cytometric analysis 
comparing uninduced and aTc-induced parasites revealed an ~80% regulation in KAHRP-
GFP expression level (Supplementary Fig. 6b). A low GFP expressing but aTc non-
responsive sub-population observed during flow cytometry likely reflects heterogeneity 
arising from episomal expression20. Consistent with this interpretation, we always observe 
single peaks of GFP expression that shift homogenously in response to aTc when using 
strains in which the regulated reporter is chromosomally integrated (Supplementary Fig. 
5b,c).
Regulating native gene expression to study function
Next, we selected a second native parasite gene, the P. falciparum chloroquine resistance 
transporter (PfCRT; PF3D7_0709000), to functionally regulate its expression and illustrate 
the utility of our system. The rationale for selecting this target was two fold in that PfCRT 
is: (1) trafficked to the parasite’s digestive vacuole and has been recalcitrant to functional 
regulation by existing methods5; and (2) an important antimalarial drug resistance 
determinant and target. We reasoned that establishing a validated line in which PfCRT 
expression is dynamically regulated would create an informative proof-of-concept model 
context, and serve as a useful reagent in future drug discovery efforts centered on interfering 
with PfCRT function. In this implementation, we also sought to demonstrate an efficient and 
generalizable strategy for installing regulatory TetR aptamers within a native chromosomal 
locus. This allows for dynamic control of target gene expression in isogenic parasite lines. 
We used a zinc finger nuclease (ZFN) targeting the PfCRT locus28 to efficiently replace the 
chloroquine (Cq)-sensitive allele (PfCRT3D7) in 3D7 parasites with a resistant allele 
(PfCRTDd2)regulated by the functional aptamer (5-1.17) or sham-regulated by the non-
functional mutant (5-1.17m2)(Fig.4a). The donor plasmids (pSG594/595) used to repair the 
ZFN-induced DNA double strand breaks were designed with a recoded PfCRT exon 1 to 
limit homology to the native locus. This ensures that repair initiated within the region 
homologous to the native 5′UTR is strongly favored, and that the sequence encoding the 
aptamer is reliably introduced at the chromosomal locus. Additionally, our donor plasmids 
are recoded at the ZFN cut site to ensure that chromosomal editing is irreversible. We co-
transfected then co-selected for both ZFN and repair plasmids for two weeks, after which we 
selected only for the donor plasmid. Under these conditions, more than 50% of isolated 
clones were PCR positive for the desired integration outcome (Supplementary Fig. 7), which 
is similar to the repair efficiency reported by Straimer et al when using this ZFN pair to edit 
the PfCRT locus28. Both the aptamer and sham regulated lines grew at approximately half 
the rate of the parental 3D7 strain. This could be due to a decrease in maximum PfCRT 
expression caused by the combined effect of aptamer insertion described earlier and 
replacement of the intron-containing allele with a cDNA-based one. Indeed, previous studies 
have shown that cDNA-based PfCRTDd2 alleles are expressed at lower levels29 and that 
decreased expression is associated with reduced growth relative to parental strains with 
intron-containing alleles30. Furthermore, while lines with a PfCRTDd2 cDNA-based allele 
could readily be obtained in the GC03 genetic back ground that was derived in a cross 
between the CQ-sensitive HB3 and CQ-resistant Dd231, attempts to generate this genotype 
in the CQ-sensitive 3D7 background by single crossover recombination were 
unsuccessful32. This suggests that a significant fitness cost is associated with expressing the 
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PfCRTDd2 cDNA allele in a3D7 background, as used in our studies, and this likely also 
contributes to the growth defect in our derived lines.
An extremely valuable step in drug target identification and validation is the ability to 
directly link the effect of a compound to its putative target. We examined the suitability of 
our system for this purpose by measuring parasite growth in the presence of 
desethylchloroquine (dCq), a potent Cqmetabolite, when PfCRT expression is either 
repressed (− aTc) or induced (+ aTc). We used dCq instead of Cqas mutant PfCRT alleles 
expressed on the Cq-sensitive 3D7 background become significantly resistant to dCq but not 
Cq, likely because additional genetic and/or epigenetic changes present in inherently 
resistant strains contribute to imparting high-level resistance to both Cq and dCq32. 
Consistent with this, we detected no increased resistance to Cq in any of our parasite lines 
expressing the PfCRTDd2 allele. However, in experiments where dCq was used, and 
PfCRTDd2 expression controlled by the active aptamer, aTc increased the IC50dCq from 
120nM (95% CI: 113-127 nM) to 324nM (95% CI: 303-345 nM), as is expected when 
increasing the expression level of this drug resistance determinant (Fig. 4b,c). No aTc-
dependent effect on dCq sensitivity was observed in the mutant aptamer line [IC50dCq = 
348nM (-aTc); 95% CI: 305-396 nM and 347 nM (+aTc); 95% CI: 287-419 nM)]. This rules 
out a direct interaction between dCq and aTc as the basis for the observations with the 
functional aptamer. Furthermore, as the functional aptamer and its non-functional control 
differ only in their non-coding region, the identical PfCRT protein component is made in 
both cases. Therefore, the observed phenotypes are not due to the production of functionally 
distinct PfCRT protein. We note here that some PfCRTDd2 expression occurs in the 
repressed state, and this confers some basal resistance to dCQ (IC50 ~ 120 nM) compared to 
the parental line (IC50 ~ 20 nM). This is consistent with our earlier data (Fig. 1c,d) showing 
that expression is substantially reduced but not completely abolished in the repressed state.
We further illustrated the utility of the TetR-aptamer system in the drug target identification 
framework by determining the aTc-dependence of verapamil-mediated reversal of dCq 
resistance. Verapamil (VP) directly interacts with PfCRT33 to inhibit the efflux of toxic 4-
aminoquinoline drugs, such as dCq, from the digestive vacuole. Thus, when PfCRT 
expression is reduced, a lower VP concentration should be required to re-sensitize parasites 
to dCq than when PfCRT expression is increased. Consistent with this model, VP almost 
completely reversed parasite resistance to dCq when PfCRTDd2 expression in the aptamer-
regulated line was repressed [IC50dCQ = 60 nM (-aTc, +VP); 95% CI: 56-64 nM](Fig.4c). 
However, induction of PfCRTDd2 expression significantly limited this reversal effect 
[IC50dCQ = 167 nM (+aTc, +VP); 95% CI: 137-205 nM], and these parasites remained 
similarly resistant to dCq as un induced parasites that were not VP treated(Fig. 4c). In 
mutant aptamer lines, VP increased dCQ sensitivity, but this was aTc-independent [IC50dCQ 
= 150 nM (-aTc, +VP); 95% CI: 123-183 versus 167 nM (+aTc, +VP); 95% CI: 137-205 
nM]. Taken together, these data support a potentially generalizable strategy for using the 
TetR-aptamer system to modulate the expression level of pre-specified molecular 
determinants to probe their mechanistic role in parasite sensitivity/resistance to candidate or 
established antimalarial drugs.
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Discussion
In summary, we have built and demonstrated a tool with broad utility for controlling gene 
expression in P. falciparum. Because this system functions reliably with no apparent 
dependence on parameters such as 5′UTR length or sequence, target gene sequence, or 
subcellular trafficking of the regulated protein, it represents a versatile addition to the 
malaria research toolset. Additionally, unlike ribozyme-based systems where only the RNA 
component can be engineered to improve functionality, our system provides the opportunity 
to engineer both the RNA element and TetR protein component34 to extend and improve 
regulatory behavior. Lastly, given that our system is based on fundamental principles of 
eukaryotic translational regulation, we envision that it will be broadly applicable and easily 
adaptable to other pathogenic organisms for which robust tools for inducible gene 
expression are currently lacking.
Methods
Molecular cloning
Cloning was performed by standard restriction/ligation, yeast homologous recombination, or 
Gibson assembly methods as described15 Unless otherwise noted, enzymes were from New 
England Biolabs and reagents were from Sigma-Aldrich, Research Products International, 
GoldBio Technology, or Alfa Aesar. PCR amplification of parasite DNA was performed 
either directly on infected red blood cells (diluted 1:50 into the reaction) or on purified DNA 
templates using Hemo Klen Taq mixed 15:1 (v:v) with PfuTurbo (Agilent). Plasmid DNA 
was prepared for transfection using Maxi Columns (Epoch Life Science) or the Xtra Midi 
Kit (Clontech).
Plasmid DNA sequences and sources
GenBank files for the constructs used in this study are provided as supplementary files. 
FLuc is wild-type firefly luciferase DNA carrying the K549E mutation for cytosolic 
targeting in yeast35. Green fluorescent protein is GFPmut236, cloned from pFGNr (Malaria 
Research and Reference Reagent Resource Center, MR4; www.mr4.org).
P. falciparum culture and transfection
Parasites were grown in human erythrocytes at 2% hematocrit under 5% O2 and 5% CO2 in 
RPMI1640 media supplemented with 5 g/L Albumax II (Life Technologies), 2 g/L 
NaHCO325 mM HEPES-K pH 7.4, 1 mM hypoxanthine and 50 mg/L gentamicin. 
Transfections used 25-75 µg of each plasmid per 200 µL packed RBC, adjusted to 50% 
hematocrit, and were performed by the spontaneous DNA uptake method37. Electroporation 
was performed on a Bio-Rad Gene Pulser II with 8 square-wave pulses of 365 V for 1 ms, 
separated by 100 ms. Transfected parasites were selected with 2.5 mg/L Blasticidin S, 5 nM 
WR9920 (Jacobus Pharmaceuticals) and/or 250 mg/L G418 beginning 4 days after 
transfection. In the case of Bxb1-mediated integration, no selection was applied on the 
integrase-expressing plasmid. All chromosomally-modified strains were confirmed by 
diagnostic PCR and sequencing of these products.
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Luciferase measurement
Dual measurement of FLuc and coelenterazine-utilizing luciferases was performed either 
with the Dual Luciferase Assay (Promega) or with homemade reagents as described13. 
Single measurement of GLucSDEL was performed by adding one volume of sample to ten 
volumes of assay buffer (0.5× phosphate-buffered saline, 0.025% Nonidet P-40, 1 µg/mL 
coelenterazine). Luciferase intensity was measured on a GloMax 20/20 luminometer (Turner 
Biosystems) or a Spectramax L plate reader (Molecular Devices). Minimum signals 
obtained using transient and stably transfected lines were ≥ 5-fold and ≥103-fold above 
background, respectively, and within instrumentation linear response ranges.
Flow cytometry
Late-stage infected red blood cells were enriched with a MACS LD column 
(MiltenyiBiotec) and stained for nucleic acid content with 1 µM SYTO 61 (Life 
Technologies) before analysis on an Accuri C6 flow cytometer (BD Biosciences). GFP was 
analyzed in FL1-H and SYTO 61 in FL4-H. Parasites were gated on high FL4 intensity to 
eliminate contaminating uninfected RBCs. Addition of aTc to either uninfected or non-
fluorescent infected red blood cells had no effect on FL1-H intensity.
GFP ELISA
Late-stage infected red blood cells were enriched with a MACS LD column 
(MiltenyiBiotec) and red blood cell membranes were lysed with 0.5 g/L saponin in PBS. 
Parasites were washed repeatedly with PBS to remove visibly detectable hemoglobin and 
stored at −80°C. As hemoglobin-depleted parasite fractions were analyzed, KAHRP-
targeted GFP was not analyzed by this method. Parasite lysates were prepared and GFP 
content was analyzed with the GFP ELISA kit (Abcam ab117992). Wells were loaded with 
equal amounts of total extracted protein as determined by BCA protein assay (Thermo 
Scientific). GFP− 3D7 parasites were used as a background control and to establish that the 
inclusion of aTc did not affect background signal intensity.
Sample preparation for immunofluorescent microscopy
Late-stage infected red blood cells were prepared by a method modified from Gallagher et 
al.38 Cells were pelleted and resuspended in fixation solution (PBS + 4% formaldehyde + 
4% glutaraldehyde) at 0.2% hematocrit. Fixation solution was prepared fresh from reagents 
in methanol-free ampules. Cells were immediately spotted onto polyethyleneimine-coated 
glass slides and incubated at room temperature for 30 min. An Immunopen (EMD 
Biosciences) was used to contain the cell suspension in a small droplet. Attached cells were 
washed with PBS and permeablized by incubating in 1% Triton X-100 in PBS for 10 min. 
Cells were then washed with PBS and blocked/quenched with 3% bovine serum albumin 
and 150 mM glycine in PBS for 1 hr. Cells were probed with mouse monoclonal anti-GFP 
(12A6, 1:25) and rabbit anti-ACP (1:500) in 3% BSA in PBS at 4 °C overnight, washed with 
PBS, and probed with CF488A-conjugated donkey anti-mouse (Biotium 20014-1, 1:1000) 
and CF647-conjugated goat anti-rabbit (Biotium 20282-1, 1:1000) for 1 hr at room 
temperature in the dark. Slides were washed with PBS and a #1.5 coverslip was mounted 
with ProLong Gold and DAPI (Life Technologies) followed by incubation in the dark for at 
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least 12 h before sealing and imaging. The GFP monoclonal antibody 12A6, developed by P. 
J. Sanchez, K. J. Daniels, and D. R. Soll, was obtained from the Developmental Studies 
Hybridoma Bank, under the auspices of the NICHD and maintained by The University of 
Iowa, Department of Biology, Iowa City, IA 52242.
Sample preparation for live fluorescence microscopy
Late-stage infected red blood cell cultures were resuspended in Albumax-free growth media 
and attached to polyethyleneimine-coated glass-bottom dishes (MatTek) before staining for 
30 min with 2 µg/mL Hoechst 33342 (Life Technologies), washing, and resuspension in 
Opti-Klear imaging buffer (Marker Gene Technologies). For mitochondrial staining, 
cultures were incubated at 37 °C for 15 min in growth media containing 25 nM Mito 
Tracker Deep Red FM (Life Technologies) before attachment.
Fluorescence microscopy
Imaging was performed on a Zeiss Axio Observer microcope with a 100× objective. For 
each field, a 30-image Z-stack was deconvolved with Huygens Essential software (SVI). 
Maximum intensity Z-projections, false coloring, and image merging were performed with 
Image J software39.
Quantitative PCR
qPCR was performed as described13 with Prime Time 5′ nuclease assays (Integrated DNA 
Technologies). P. falciparum RNA was extracted directly from late-stage infected red blood 
cells with Trizol (Life Technologies) and purified with an RN easy kit (Qiagen). cDNA was 
prepared with SuperScript III reverse transcriptase (Life Technologies). PF3D7_1331700 
(glutamine-tRNA ligase) was used as a housekeeping reference gene. Primer and probe 
sequences are listed in Supplementary Table 2.
ZFN-mediated editing of the PfCRT locus
Parasites were co-transfected with ZFN-expressing plasmid (expressing blasticidin 
resistance) and a donor vector (expressing WR99210 resistance). Four days after 
transfection, cultures were selected with 2.5 mg/L blasticidin and 2.5 nM WR99210 for 2 
weeks, at which point blasticidin selection was removed. During transfection and routine 
culturing, parasites were always maintained in the presence of 0.4 µM aTc. ATc was only 
removed as needed for specific experiments. Proper repair of the PfCRT locus with aptamer 
integration was confirmed by PCR in bulk culture and after cloning by limiting dilution. 
Greater than 50% of the clones isolated were PCR-positive for the integration event.
Drug toxicity assays
Parasite growth in the presence or absence of antimalarial drugs was monitored with the 
Gaussia luciferase reporter GLucSDEL. The full-length Gaussia luciferase (human codon-
optimized, New England Biolabs) was fused at its C terminus to the endoplasmic retention 
signal peptide SDEL, yielding extremely high coelenterazine-dependent luciferase reporter 
activity in P. falciparum. The high activity and stability of GLucSDEL allows monitoring of 
luciferase activity in the culture supernatant. For drug toxicity assays, synchronous ring-
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stage cultures were seeded in 96-well plates at 0.5% hematocrit and ~0.5% parasitemia. 
Serial dilutions of desethylchloroquine (Santa Cruz Biotech) were added to a final 
concentration of 0 or 19.5–5000 nM and cultures were incubated for 96 h. When applicable, 
verapamil (Enzo Life Sciences) was used at 0.8 µM. Plates were briefly centrifuged and 20 
µL of culture supernatant was assayed for Gaussia luciferase activity as described above. 
Each experiment was performed in triplicate, and the positions of each condition (different 
strains and aTc induction conditions) were systematically varied to eliminate position bias. 
Luciferase-null background signal (from strain 3D7) was subtracted and luciferase 
intensities were normalized to the no drug conditions. IC50 values and 95% confidence 
intervals were determined by nonlinear regression with Prism software (GraphPad).
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Figure 1. Aptamer5-1.17enables aTc-dependent control of reporter gene expression
(a) A schematic of aTc- and TetR- dependent regulation of translation is shown. (b) Plasmid 
vectors pSG75 (CaM 5′UTR with 5-1.17), pSG76 (CaM 5′UTR with 5-1.17m2) and 
pSG216 (hsp86 5′UTR with 5-1.17) were used to screen for aTc-dependent regulation in 
transient transfections. Vectors pSG231 (5-1.17) and pSG252(5-1.17m2) were used for the 
same purposes in stable episomal parasite lines. Either a functional (5-1.17) or mutated 
(5-1.17m2) aptamer was placed upstream of the FLuc reporter gene to regulate its 
expression. The sequence and placement context for the 5-1.17 aptamer is shown as an in 
set. The capitalized ‘A’s are mutated to ‘T’s to produce the non-functional 5-1.17m2. Bases 
in italics indicate a short upstream start/stop, and those in bold indicate a productive start 
codon that is kept in frame with the downstream coding sequence (CDS) of interest. A CDS 
may carry its own initiation codon, or not, with no effect on expression or regulation by aTc. 
Renilla luciferase (RLuc) is expressed constitutively, and serves as a reference during 
quantitation. (c) During transient screening in the TetR-expressing parasite clone B10, 
5-1.17, but not 5-1.17m2, results in aTc-inducible FLuc expression. Values are expressed as 
FLuc/RLuc (− aTc) normalized to FLuc/RLuc(+ aTc). (d) Similarly, in stable episomal 
lines, 5-1.17 but not 5-1.17m2, resulted in aTc-inducible FLuc expression. (e) Insertion of 
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aptamer5-1.17 down stream of the CaM 5′UTR reduces its maximal FLuc expression about 
two fold. All data are expressed as the mean ± s.d. of 2-4 independent experiments. An 
asterisk (*) denotes a p-value ≤ 0.002 determined by two-tailed unpaired t-test.
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Figure 2. Rapid induction and washout kinetics are achieved using the TetR-aptamer system in 
P. falciparum
Dd2 strain parasites harboring pSG231 (5-1.17/FLuc) or pSG252 (5-1.17m2/FLuc) were 
tightly synchronized. aTc (1 µM) was added, removed, or maintained at the time indicated 
by the arrowhead. Dual luciferase measurements were made at various time points, and 
relative FLuc/RLuc ratios were determined. (a) aTc status was adjusted in late stage 
parasites just prior to reinvasion, and FLuc/RLuc monitored over the next IDC; (b) aTc 
status was adjusted at early ring stage, and FLuc/RLuc monitored within that IDC. Values 
represent the mean ± s.d. of three biological replicates. An asterisk (*) denotes a p-value ≤ 
0.001 as determined by two-way ANOVA. N.S. = not significant.
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Figure 3. Aptamer controlled target proteins are properly trafficked to various subcellular 
compartments
(a) Immunofluorescence and live fluorescence imaging of strains expressing 
chromosomally-integrated GFP reporters bearing an N-terminal targeting peptide (Api = 
apicoplast-targeted; Mito = mitochondrion-targeted; PEXEL = protein export to erythrocyte 
cytoplasm). ACP = acyl carrier protein, used as an apicoplast marker. (b) Live fluorescence 
imaging of aptamer-regulated KAHRP-GFP fusion expressed from an episomal construct 
bearing the P. falciparum centromere-derived element pfCEN5-1.5.
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Figure 4. Aptamer-mediated functional regulation of PfCRT expression from its native 
chromosomal context
(a) Schematic of modified PfCRT locus to simultaneously introduce 5-1.17 (clone H2) and 
5-1.17m2 (clone C1) and the regulatory TetR protein. (b) Aptamer 5-1.17 regulates the 
sensitivity of clone H2 to dCQ, while the non-functional 5-1.17m2 does not modulate the 
sensitivity of clone C1 to dCQ. (c) Verapamil (VP), which reverses resistance to dCQ 
through a direct interaction with PfCRT, is less effective when PfCRT expression is induced 
versus repressed. Clone E3 (control) has a wild-type PfCRT3D7 locus and a constitutive 
GLucSDEL reporter integrated at the cg6 locus, and exhibits an aTc- and verapamil- 
independent IC50dCQ = 20 nM (95% CI: 15-26 nM) Data were collected in biological 
triplicates. Mean values and error bars representing 95% confidence intervals are reported.
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